Skip to main content
Erschienen in: Obesity Surgery 2/2020

25.11.2019 | New Concept

Single-Anastomosis Sleeve Jejunal Bypass, a Novel Bariatric Surgery, Versus Other Familiar Methods: Results of a 6-Month Follow-up—a Comparative Study

Erschienen in: Obesity Surgery | Ausgabe 2/2020

Einloggen, um Zugang zu erhalten

Abstract

Background

Obesity and its associated morbidities have become a significant concern all over the world. Bariatric surgery, regardless of its type, is the most effective approach for treating morbid obesity. Single-anastomosis sleeve jejunal (SASJ) bypass is a novel bariatric surgery technique and can be considered for patients with former background of severe gastroesophageal symptoms. The purpose of this research was to compare SASJ bypass outcomes with other techniques during a 6-month follow-up.

Methods

This is a non-randomized clinical trial conducted on 100 patients, who underwent four types of bariatric surgery (classic Roux-en-Y bypass, SASJ bypass, omega gastric bypass, and sleeve gastrectomy), and each one of these types contained 25 cases, during the time period of 2 years from 2016 to 2018. Patients’ information including age, gender, height, basal weight, body mass index (BMI), serum albumin, and hemoglobin A1C were recorded, within 1, 3, and 6 months after their surgery, and also were compared with each other.

Results

Members of the four groups were similar due to their age, gender distribution, height, baseline BMI, hemoglobin A1C, albumin, and also excess weight (P value > 0.05); however, the sleeve gastrectomy group baseline weight was significantly higher compared with the other three groups (P value = 0.013). All of the groups significantly lost weight during this 6-month period, but the comparison between them indicated no statistical difference regarding excess weight loss, BMI, hemoglobin A1C, and albumin (P value > 0.05). The excess weight loss mean during 6 months in SASJ bypass was 34.2 ± 5.4%, which was comparable with other groups.

Conclusions

The weight loss trend after the SASJ bypass was similar to that of older techniques; consequently this technique can be considered for cases with particular indications due to the reversibility and also more accessible gastric follow-up studies in the SASJ approach. Further researches with longer follow-ups are strongly recommended.
Literatur
1.
Zurück zum Zitat Dixon J. The global burden of obesity and diabetes. In: Minimally invasive bariatric surgery. New York: Springer; 2015. p. 1–6. Dixon J. The global burden of obesity and diabetes. In: Minimally invasive bariatric surgery. New York: Springer; 2015. p. 1–6.
2.
Zurück zum Zitat Nguyen NT, Varela JE. Bariatric surgery for obesity and metabolic disorders: state of the art. Nat Rev Gastroenterol Hepatol. 2017;14(3):160–9.CrossRefPubMed Nguyen NT, Varela JE. Bariatric surgery for obesity and metabolic disorders: state of the art. Nat Rev Gastroenterol Hepatol. 2017;14(3):160–9.CrossRefPubMed
3.
Zurück zum Zitat Picot J, Jones J, Colquitt J, et al. The clinical effectiveness and cost-effectiveness of bariatric (weight loss) surgery for obesity: a systematic review and economic evaluation. Health Technol Assess. 2009;13(41):1–214.CrossRefPubMed Picot J, Jones J, Colquitt J, et al. The clinical effectiveness and cost-effectiveness of bariatric (weight loss) surgery for obesity: a systematic review and economic evaluation. Health Technol Assess. 2009;13(41):1–214.CrossRefPubMed
4.
Zurück zum Zitat Colquitt JL, Pickett K, Loveman E, et al. Surgery for weight loss in adults. Cochrane Database Syst Rev. 2014;8 Colquitt JL, Pickett K, Loveman E, et al. Surgery for weight loss in adults. Cochrane Database Syst Rev. 2014;8
5.
Zurück zum Zitat Angrisani L, Santonicola A, Iovino P, et al. Bariatric surgery worldwide 2013. Obes Surg. 2015;25(10):1822–32.PubMed Angrisani L, Santonicola A, Iovino P, et al. Bariatric surgery worldwide 2013. Obes Surg. 2015;25(10):1822–32.PubMed
6.
Zurück zum Zitat Santoro S, Milleo FQ, Malzoni CE, et al. Enterohormonal changes after digestive adaptation: five-year results of a surgical proposal to treat obesity and associated diseases. Obes Surg. 2008;18(1):17–26.CrossRefPubMed Santoro S, Milleo FQ, Malzoni CE, et al. Enterohormonal changes after digestive adaptation: five-year results of a surgical proposal to treat obesity and associated diseases. Obes Surg. 2008;18(1):17–26.CrossRefPubMed
8.
Zurück zum Zitat Alamo MA, Torres CS, Perez LZ. Vertical isolated gastroplasty with gastro-enteral bypass: preliminary results. Obes Surg. 2006;16(3):353–8.CrossRef Alamo MA, Torres CS, Perez LZ. Vertical isolated gastroplasty with gastro-enteral bypass: preliminary results. Obes Surg. 2006;16(3):353–8.CrossRef
9.
Zurück zum Zitat de Menezes JEMT, Azaro E, Mello CAB, et al. Analysis of the vertical isolated gastroplasty: a new bariatric operation. Obes Surg. 2006;16(9):1263–5.CrossRef de Menezes JEMT, Azaro E, Mello CAB, et al. Analysis of the vertical isolated gastroplasty: a new bariatric operation. Obes Surg. 2006;16(9):1263–5.CrossRef
10.
Zurück zum Zitat Huang C-K, Mahendra R, Hsin M-C, et al. Novel metabolic surgery: first Asia series and short-term results of laparoscopic proximal jejunal bypass with sleeve gastrectomy. Ann Laparosc Endosc Surg. 2016;1(7)CrossRef Huang C-K, Mahendra R, Hsin M-C, et al. Novel metabolic surgery: first Asia series and short-term results of laparoscopic proximal jejunal bypass with sleeve gastrectomy. Ann Laparosc Endosc Surg. 2016;1(7)CrossRef
11.
Zurück zum Zitat Alamo M, Sepúlveda M, Gellona J, et al. Sleeve gastrectomy with jejunal bypass for the treatment of type 2 diabetes mellitus in patients with body mass index<35 kg/m 2. A Cohort Study. Obes Surg. 2012;22(7):1097–103.CrossRefPubMed Alamo M, Sepúlveda M, Gellona J, et al. Sleeve gastrectomy with jejunal bypass for the treatment of type 2 diabetes mellitus in patients with body mass index<35 kg/m 2. A Cohort Study. Obes Surg. 2012;22(7):1097–103.CrossRefPubMed
12.
Zurück zum Zitat Wittgrove AC, Clark GW. Laparoscopic gastric bypass, Roux en-Y-500 patients: technique and results, with 3-60 month follow-up. Obes Surg. 2000;10(3):233–9.CrossRefPubMed Wittgrove AC, Clark GW. Laparoscopic gastric bypass, Roux en-Y-500 patients: technique and results, with 3-60 month follow-up. Obes Surg. 2000;10(3):233–9.CrossRefPubMed
13.
Zurück zum Zitat Pazouki A, Kermansaravi M. Single anastomosis sleeve-jejunal bypass: a new method of bariatric/metabolic surgery. Obes Surg. 2019:1–2. Pazouki A, Kermansaravi M. Single anastomosis sleeve-jejunal bypass: a new method of bariatric/metabolic surgery. Obes Surg. 2019:1–2.
14.
Zurück zum Zitat Madan AK, Harper JL, Tichansky DS. Techniques of laparoscopic gastric bypass: on-line survey of American Society for Bariatric Surgery practicing surgeons. Surg Obes Relat Dis. 2008;4(2):166–72.CrossRefPubMed Madan AK, Harper JL, Tichansky DS. Techniques of laparoscopic gastric bypass: on-line survey of American Society for Bariatric Surgery practicing surgeons. Surg Obes Relat Dis. 2008;4(2):166–72.CrossRefPubMed
15.
Zurück zum Zitat Roa PE, Kaidar-Person O, Pinto D, et al. Laparoscopic sleeve gastrectomy as treatment for morbid obesity: technique and short-term outcome. Obes Surg. 2006;16(10):1323–6.CrossRefPubMed Roa PE, Kaidar-Person O, Pinto D, et al. Laparoscopic sleeve gastrectomy as treatment for morbid obesity: technique and short-term outcome. Obes Surg. 2006;16(10):1323–6.CrossRefPubMed
16.
Zurück zum Zitat Deitel M, Greenstein RJ. Recommendations for reporting weight loss. Obes Surg. 2003;13(2):159–60.CrossRefPubMed Deitel M, Greenstein RJ. Recommendations for reporting weight loss. Obes Surg. 2003;13(2):159–60.CrossRefPubMed
17.
Zurück zum Zitat O’Brien PE, MacDonald L, Anderson M, et al. Long-term outcomes after bariatric surgery: fifteen-year follow-up of adjustable gastric banding and a systematic review of the bariatric surgical literature. Ann Surg. 2013;257(1):87–94.CrossRefPubMed O’Brien PE, MacDonald L, Anderson M, et al. Long-term outcomes after bariatric surgery: fifteen-year follow-up of adjustable gastric banding and a systematic review of the bariatric surgical literature. Ann Surg. 2013;257(1):87–94.CrossRefPubMed
18.
Zurück zum Zitat Birkmeyer JD, Finks JF, O’reilly A, et al. Surgical skill and complication rates after bariatric surgery. N Engl J Med. 2013;369(15):1434–42.CrossRefPubMed Birkmeyer JD, Finks JF, O’reilly A, et al. Surgical skill and complication rates after bariatric surgery. N Engl J Med. 2013;369(15):1434–42.CrossRefPubMed
20.
Zurück zum Zitat Lustig RH. The neuroendocrinology of obesity. Endocrinol Metab Clin N Am. 2001;30(3):765–85.CrossRef Lustig RH. The neuroendocrinology of obesity. Endocrinol Metab Clin N Am. 2001;30(3):765–85.CrossRef
21.
Zurück zum Zitat Tang-Christensen M, Vrang N, Larsen P. Glucagon-like peptide containing pathways in the regulation of feeding behaviour. Int J Obes. 2002;25(S5):S42.CrossRef Tang-Christensen M, Vrang N, Larsen P. Glucagon-like peptide containing pathways in the regulation of feeding behaviour. Int J Obes. 2002;25(S5):S42.CrossRef
22.
Zurück zum Zitat Layer P, Holst JJ, Grandt D, et al. Ileal release of glucagon-like peptide-1 (GLP-1). Dig Dis Sci. 1995;40(5):1074–82.CrossRefPubMed Layer P, Holst JJ, Grandt D, et al. Ileal release of glucagon-like peptide-1 (GLP-1). Dig Dis Sci. 1995;40(5):1074–82.CrossRefPubMed
23.
Zurück zum Zitat Neumiller JJ. Differential chemistry (structure), mechanism of action, and pharmacology of GLP-1 receptor agonists and DPP-4 inhibitors. J Am Pharm Assoc. 2009;49(5):S16–29.CrossRef Neumiller JJ. Differential chemistry (structure), mechanism of action, and pharmacology of GLP-1 receptor agonists and DPP-4 inhibitors. J Am Pharm Assoc. 2009;49(5):S16–29.CrossRef
24.
Zurück zum Zitat Kasama K, Tagaya N, Kanehira E, et al. Laparoscopic sleeve gastrectomy with duodenojejunal bypass: technique and preliminary results. Obes Surg. 2009;19(10):1341–5.CrossRefPubMed Kasama K, Tagaya N, Kanehira E, et al. Laparoscopic sleeve gastrectomy with duodenojejunal bypass: technique and preliminary results. Obes Surg. 2009;19(10):1341–5.CrossRefPubMed
25.
Zurück zum Zitat Fried M, Ribaric G, Buchwald J, et al. Metabolic surgery for the treatment of type 2 diabetes in patients with BMI< 35 kg/m 2: an integrative review of early studies. Obes Surg. 2010;20(6):776–90.CrossRefPubMed Fried M, Ribaric G, Buchwald J, et al. Metabolic surgery for the treatment of type 2 diabetes in patients with BMI< 35 kg/m 2: an integrative review of early studies. Obes Surg. 2010;20(6):776–90.CrossRefPubMed
26.
Zurück zum Zitat Mahdy T, Schou C. Efficacy of single anastomosis sleeve ileal (SASI) bypass for type-2 diabetic morbid obese patients: gastric bipartition, a novel metabolic surgery procedure: a retrospective cohort study. Int J Surg. 2016;34:28–34.CrossRefPubMed Mahdy T, Schou C. Efficacy of single anastomosis sleeve ileal (SASI) bypass for type-2 diabetic morbid obese patients: gastric bipartition, a novel metabolic surgery procedure: a retrospective cohort study. Int J Surg. 2016;34:28–34.CrossRefPubMed
27.
Zurück zum Zitat Melissas J, Peppe A, Askoxilakis J, et al. Sleeve gastrectomy plus side-to-side jejunoileal anastomosis for the treatment of morbid obesity and metabolic diseases: a promising operation. Obes Surg. 2012;22(7):1104–9.CrossRefPubMed Melissas J, Peppe A, Askoxilakis J, et al. Sleeve gastrectomy plus side-to-side jejunoileal anastomosis for the treatment of morbid obesity and metabolic diseases: a promising operation. Obes Surg. 2012;22(7):1104–9.CrossRefPubMed
28.
Zurück zum Zitat Zachariah PJ, Chen C-Y, Lee W-J, et al. Compared to sleeve gastrectomy, duodenal–jejunal bypass with sleeve gastrectomy gives better glycemic control in T2DM patients, with a lower β-cell response and similar appetite sensations: mixed-meal study. Obes Surg. 2016;26(12):2862–72.CrossRefPubMed Zachariah PJ, Chen C-Y, Lee W-J, et al. Compared to sleeve gastrectomy, duodenal–jejunal bypass with sleeve gastrectomy gives better glycemic control in T2DM patients, with a lower β-cell response and similar appetite sensations: mixed-meal study. Obes Surg. 2016;26(12):2862–72.CrossRefPubMed
29.
Zurück zum Zitat Lee W-J, Almulaifi AM, Tsou J-J, et al. Duodenal–jejunal bypass with sleeve gastrectomy versus the sleeve gastrectomy procedure alone: the role of duodenal exclusion. Surg Obes Relat Dis. 2015;11(4):765–70.CrossRefPubMed Lee W-J, Almulaifi AM, Tsou J-J, et al. Duodenal–jejunal bypass with sleeve gastrectomy versus the sleeve gastrectomy procedure alone: the role of duodenal exclusion. Surg Obes Relat Dis. 2015;11(4):765–70.CrossRefPubMed
30.
Zurück zum Zitat Sánchez-Pernaute A, Rubio MÁ, Cabrerizo L, et al. Single-anastomosis duodenoileal bypass with sleeve gastrectomy (SADI-S) for obese diabetic patients. Surg Obes Relat Dis. 2015;11(5):1092–8.CrossRefPubMed Sánchez-Pernaute A, Rubio MÁ, Cabrerizo L, et al. Single-anastomosis duodenoileal bypass with sleeve gastrectomy (SADI-S) for obese diabetic patients. Surg Obes Relat Dis. 2015;11(5):1092–8.CrossRefPubMed
31.
Zurück zum Zitat Jammu GS, Sharma R. A 7-year clinical audit of 1107 cases comparing sleeve gastrectomy, Roux-En-Y gastric bypass, and mini-gastric bypass, to determine an effective and safe bariatric and metabolic procedure. Obes Surg. 2016;26(5):926–32.CrossRefPubMed Jammu GS, Sharma R. A 7-year clinical audit of 1107 cases comparing sleeve gastrectomy, Roux-En-Y gastric bypass, and mini-gastric bypass, to determine an effective and safe bariatric and metabolic procedure. Obes Surg. 2016;26(5):926–32.CrossRefPubMed
Metadaten
Titel
Single-Anastomosis Sleeve Jejunal Bypass, a Novel Bariatric Surgery, Versus Other Familiar Methods: Results of a 6-Month Follow-up—a Comparative Study
Publikationsdatum
25.11.2019
Erschienen in
Obesity Surgery / Ausgabe 2/2020
Print ISSN: 0960-8923
Elektronische ISSN: 1708-0428
DOI
https://doi.org/10.1007/s11695-019-04266-9

Weitere Artikel der Ausgabe 2/2020

Obesity Surgery 2/2020 Zur Ausgabe

Letter to Editor/LED Reply

Commentary: Cancer after the OAGB-MGB

Update Chirurgie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

S3-Leitlinie „Diagnostik und Therapie des Karpaltunnelsyndroms“

Karpaltunnelsyndrom BDC Leitlinien Webinare
CME: 2 Punkte

Das Karpaltunnelsyndrom ist die häufigste Kompressionsneuropathie peripherer Nerven. Obwohl die Anamnese mit dem nächtlichen Einschlafen der Hand (Brachialgia parästhetica nocturna) sehr typisch ist, ist eine klinisch-neurologische Untersuchung und Elektroneurografie in manchen Fällen auch eine Neurosonografie erforderlich. Im Anfangsstadium sind konservative Maßnahmen (Handgelenksschiene, Ergotherapie) empfehlenswert. Bei nicht Ansprechen der konservativen Therapie oder Auftreten von neurologischen Ausfällen ist eine Dekompression des N. medianus am Karpaltunnel indiziert.

Prof. Dr. med. Gregor Antoniadis
Berufsverband der Deutschen Chirurgie e.V.

S2e-Leitlinie „Distale Radiusfraktur“

Radiusfraktur BDC Leitlinien Webinare
CME: 2 Punkte

Das Webinar beschäftigt sich mit Fragen und Antworten zu Diagnostik und Klassifikation sowie Möglichkeiten des Ausschlusses von Zusatzverletzungen. Die Referenten erläutern, welche Frakturen konservativ behandelt werden können und wie. Das Webinar beantwortet die Frage nach aktuellen operativen Therapiekonzepten: Welcher Zugang, welches Osteosynthesematerial? Auf was muss bei der Nachbehandlung der distalen Radiusfraktur geachtet werden?

PD Dr. med. Oliver Pieske
Dr. med. Benjamin Meyknecht
Berufsverband der Deutschen Chirurgie e.V.

S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“

Appendizitis BDC Leitlinien Webinare
CME: 2 Punkte

Inhalte des Webinars zur S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“ sind die Darstellung des Projektes und des Erstellungswegs zur S1-Leitlinie, die Erläuterung der klinischen Relevanz der Klassifikation EAES 2015, die wissenschaftliche Begründung der wichtigsten Empfehlungen und die Darstellung stadiengerechter Therapieoptionen.

Dr. med. Mihailo Andric
Berufsverband der Deutschen Chirurgie e.V.